Ro

Telehealth platform offering primary care, men's health, women's health, and weight management through 50-state provider network and fully integrated pharmacy.

HealthcareUnited States·Founded 2017·ISO/NSO equity·ro.co ↗

Compare ⇄Calculate →

Source review Jun 2026 — source URL pending

Reference estimate only

4 methods · Source review Jun 2026 — source URL pendingLow confidence (34%)

The four valuation methods disagree significantly (10.9× spread). Treat this as a wide reference range only — not a reliable point estimate.

$7B

wide range · ~$4B – ~$39B

Implied per-share: $98.0 · vs last primary +208%

No verified public secondary-market signal available for Ro. The estimate relies on last confirmed financing, peer multiples, sector momentum, and time decay.

Valuation basis:Last primary roundSource review Jun 2026 — source URL pending

Last primary round

$7B

Series D · 53mo ago

Secondary signal

—

No verified secondary signal

No verified public secondary signal is available. Hiive/Forge links are monitoring links only, not evidence of a current executable price.

Headcount

1,200

employees · LinkedIn+9%

LinkedIn count — directional proxy only. Historical figure sourced via Wayback Machine; treat ±15% as normal variance.

Revenue (est.)

$600M

annual run rate · est.

Complete company data

Every input we use, where we got it from, and how much we trust it.

⚠

Source review: key primary-round source URL still pending. Figures are retained as historical reference and marked low-confidence where applicable.

Field	Value	Source & Verification	Confidence
Company fundamentals
Sector	Healthcare	Editorial classification	high
Headquarters	United States	Company website · Crunchbase	high
Founded	2017	Company website · Wikipedia	high
Website	ro.co	Direct	high
Last primary round
Post-money valuation	$7B	Bloomberg Feb 2022[source URL pending]	medium
Round name	Series D	Bloomberg Feb 2022	high
Date	2022-02-16 (53 months ago)	Bloomberg Feb 2022	high
Lead investor	General Catalyst	Bloomberg Feb 2022	high
Amount raised	Not disclosed	Bloomberg Feb 2022	medium
Capitalization
Total fully-diluted shares	220M	Derived/estimated — SEC Form D filings, secondary price math, cap-table summaries[estimated — not authoritative] › notes Public total fully-diluted share count: estimated from SEC Form D filings, secondary-market pricing math (implied valuation ÷ price per share), and leaked cap-table summaries. Considered the lowest-confidence input.	low
Implied share price (illustrative only)	~$98	$7B anchor × 1000 ÷ 220M shares[derived] › notes Wide method spread — treat as illustrative mechanics only. The last primary round is a more reliable anchor for high-stakes decisions.	low
Primary equity type granted	ISO/NSO	Public reports of company equity practices	high
Financials
Annual revenue (est.)	$600M	Estimated — best available public estimates (Sacra, The Information, company ARR disclosures, press reports)[estimated — not independently verified] › notes Annual revenue: best public estimates from Sacra, The Information, WSJ leaks, or company-stated ARR. Where official, we cite the source on the funding round.	medium
EV / Revenue (implied)	11.7x	Computed from valuation ÷ revenue[derived]	medium
Headcount
Employees (now)	1,200	LinkedIn — current company page count › notes Headcount: LinkedIn 'Company' page employee count, taken now and approximately 12 months ago via the Wayback Machine. Treat as a directional proxy for revenue growth, not a hard number.	medium
Employees (12 months ago)	1,100	LinkedIn company page — historical snapshot via Wayback Machine[estimated — ±15% directional proxy]	medium
12-month headcount growth	+9%	Computed[derived]	medium
Methodology inputs
Sector ETF proxy	ARKG	Editorial choice — most representative public ETF › notes Sector ETF: editorial choice of the most representative public-market proxy. Annual return: 3-year trailing average from Yahoo Finance, refreshed quarterly.	medium
ETF annual return (trailing 3-yr)	16%	Yahoo Finance · refreshed quarterly	medium

Funding history

Primary rounds reported in Bloomberg, WSJ, TechCrunch, Reuters, or SEC Form D filings (efts.sec.gov). Linked per round below.

Valuation progression (equity rounds)

Valuation progression · equity rounds

$7.0Blatest · Series D

Total growth

58×

Our estimate

$21.6B

Primary round

Down round

Our estimate

Series D+40%2022-02-16

$7.0B

Led by General Catalyst

Source: Bloomberg Feb 2022(source URL pending)

Series D+233%2021-03-23

$5.0B

Led by General Catalyst · raised $500M

Source: TechCrunch Mar 2021(historical ref.)

Series C+275%2020-10-01

$1.5B

Led by General Catalyst · raised $200M

Source: TechCrunch Oct 2020(historical ref.)

Series B+233%2019-06-03

$0.4B

Led by General Catalyst · raised $85M

Source: TechCrunch Jun 2019(historical ref.)

Series A2018-08-01

$0.1B

Led by FirstMark Capital · raised $25M

Source: Crunchbase(historical ref.)

Secondary market signals

Secondary market signals: bid/ask/trade indications from Hiive (hiive.com), Forge Global, Caplight Index, and tender prices reported in the press.

No active listings found

We monitor Hiive, Forge Global, and EquityZen for Ro listings. As of July 2026, no verified secondary market activity has been recorded.

Secondary listings for private companies appear without announcement and typically close within days. When a listing appears, it often signals an upcoming tender offer or funding round.

Primary round history as valuation signal

In the absence of secondary market data, the funding history below is the primary valuation anchor. Method C (time-decay) uses this data to estimate current value.

Series D · 2022-02$7B

Series D · 2021-03$5B

Series C · 2020-10$1.5B

Get notified when a listing appears

Pro subscribers get notified within 2 hours when a secondary listing for Ro is detected. Most employees first hear about tender offers days after the market already knows.

Get listing alerts →

Check directly: Hiive ↗ · Forge Global ↗ · SEC Form D ↗

Public peer comparables

Public peer comparables: editorial selection of public companies with the closest business model. EV/Revenue and growth from public 10-Q filings and Bloomberg, refreshed quarterly.

Ticker	Company	EV / Revenue	Revenue growth	As of
AMWL	American Well Corporation	0.64x	+-18%	2026-07-10
DOCS	Doximity, Inc.	6.24x	+5%	2026-07-10
TDOC	Teladoc Health, Inc.	0.66x	+-3%	2026-07-10
VEEV	Veeva Systems Inc.	9.28x	+16%	2026-07-10

Confidence breakdown

How much we trust each of the four valuation methods for this specific company, and why.

Method A — Peer-multiple

weight 25%→ $76.5B75% confidence

Growth-weighted peer EV/Revenue: 170.0x → 25% private-company discount → 127.5x on $600M revenue

Method B — Secondary-implied

weight 45%suppressed25% confidence

↳ Effectively excluded from the blend — this method is structurally unreliable for this company.

No verified secondary market data available — estimate relies on primary round, peer multiples, and sector momentum.

Method C — Primary time-decay

weight 20%suppressed20% confidence

↳ Effectively excluded from the blend — this method is structurally unreliable for this company.

$7B round (2022-02-16) × 2.67× growth × 0.85× multiple decay over 4.4 years

Method D — Sector momentum

weight 10%suppressed10% confidence

↳ Effectively excluded from the blend — this method is structurally unreliable for this company.

$7B × (1 + 16% p.j.)^4.4yr = $13.6B via ARKG ETF-proxy

Overall confidence

34%

Weighted average of the four methods. Above 60% is high, 35–60% medium, below 35% low.

Low

Worked example for an employee

Illustrative mechanics only — this shows how the equity model works, not a reliable value estimate.

Illustrative mechanics only

This example shows equity mechanics only. It is not a reliable estimate of current value because model support is weak (confidence 34%, spread 10.9×).

Show illustrative values (not a reliable estimate) ▸

Profile: a hypothetical employee who joined Ro 24 months ago (2024-07-10) with 2,000 options, on the standard 4-year vesting schedule with a 1-year cliff.

Vesting

1,000 of 2,000

50% vested at month 24

Implied share price (mid)

$98

weighted average of 4 methods — low confidence

Gross vested value

$97,996

vested shares × implied price

Net value

$97,996

no strike, gross = net

Tax (rough)

$16,612

US federal only · AMT risk: medium

What if the next round is…

Up round +30%

$110,779

New round at +30% valuation, 15% new shares issued

Down round −30%

$57,165

New round at −30% valuation, 20% new shares (higher dilution in distress)

Secondary today

$83,297

Sale on the secondary market at the typical 15% discount to the mid estimate

These illustrative values use the same calculation engine as the live calculator, but the underlying model is low-confidence for Ro. Use your own numbers as a starting point only. Try the calculator →

Transparent assumptions

What we assumed where exact data isn't available. If any of these don't match your situation, the numbers above will be off.

Fully-diluted share count

220M shares

We don't have authoritative cap-table access for private companies. The number above is reconstructed from SEC Form D filings, secondary-market price-vs-valuation math, and leaked share-class summaries. Actual fully-diluted count (including unvested option pool and SAFEs) may differ by 5–15%.

Common-stock waterfall

1.0× to common

We assume a clean common-stock outcome — i.e. preferred-share liquidation preferences and ratchets do not extract value before common. In a down-exit, this assumption can be very wrong: preferred stack can take 30–70% of proceeds.

Private-company illiquidity discount

25% off public peers

Applied to Method A (peer-multiple). Per-company because category leaders with deep secondary markets and a clear IPO path warrant a smaller discount than early-stage names. The literature range is 10–35%; for Ro we use 25% based on secondary-market depth, valuation history, and proximity to liquidity.

Revenue growth assumption (Method C)

25% YoY

Compounded forward from the last primary date to today to estimate the company's value drift. Set per-company based on disclosed or reported ARR trajectory. Method C is further capped at 1.3× the most recent secondary trade (if any) to stop runaway extrapolation when revenue growth outpaces what the market is actually paying.

Sector ETF momentum (Method D)

ARKG @ 16%/year

Method D applies the trailing return of ARKG as a market-proxy adjustment to the primary valuation. Crude — meant as a tiebreaker when peer and secondary data conflict, not as a primary signal.

Outlier auto-downweight

Methods >50% from median get ½ weight

Robust-statistics safety net: any method whose output strays more than 50% from the median of the other three methods has its confidence weight halved when computing the blended mid-point. Prevents a single bad extrapolation from dragging the headline.

Recency decay for secondary trades

180-day half-life (e⁻ᵈ/¹⁸⁰)

A trade from 30 days ago counts ~5× more than one from 180 days ago. Tunable; some platforms use shorter half-lives.

Tax estimate

US federal only, single filer

Uses 2024 US federal brackets, ignoring state tax, NIIT, AMT credit recovery, and any other deductions. Treat as a directional sanity check, not a tax bill.

All data from public sources. Not investment, tax, or legal advice. Not affiliated with Ro. Last refreshed manually — see methodology for our update cadence.